Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective Controlled Study on Treatment of Giant Cavernous Hemangiomas of the Liver：RFA Versus Laparoscopic Hepatectomy.

NCT01471080 is registered in ClinicalTrials.gov with Southwest Hospital, China as lead sponsor.

NCT NCT01471080
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01471080 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective Controlled Study on Treatment of Giant Cavernous Hemangiomas of the Liver：RFA Versus Laparoscopic Hepatectomy.
Lead sponsor
Southwest Hospital, China
Phase
Not applicable
Overall status
Completed
Start date
November 30, 2011
Completion date
January 31, 2014
Enrollment
140 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

giant cavernous hemangiomas, laparoscopic hepatectomy, liver, radio-frequency ablation